Inflammation-Associated Cytokines IGFBP1 and RANTES Impair the Megakaryocytic Potential of HSCs in PT Patients after Allo-HSCT.

[1]  Fei Li,et al.  Estrogen promotes megakaryocyte polyploidization via estrogen receptor beta-mediated transcription of GATA1 , 2017, Leukemia.

[2]  O. Nedić,et al.  Interaction between fibrinogen and insulin-like growth factor-binding protein-1 in human plasma under physiological conditions , 2016, Biochemistry (Moscow).

[3]  Xiao-hui Zhang,et al.  Characterization of thrombopoietin kinetics within 60 days after allogeneic hematopoietic stem cell transplantation and its correlation with megakaryocyte ploidy distribution , 2016, Clinical transplantation.

[4]  Jiaxi Zhou,et al.  Integrated Biophysical and Biochemical Signals Augment Megakaryopoiesis and Thrombopoiesis in a Three‐Dimensional Rotary Culture System , 2016, Stem cells translational medicine.

[5]  Y. Wan,et al.  A Liver-Bone Endocrine Relay by IGFBP1 Promotes Osteoclastogenesis and Mediates FGF21-Induced Bone Resorption. , 2015, Cell metabolism.

[6]  Jiamin Zhang,et al.  Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT , 2015, Journal of Hematology & Oncology.

[7]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  Yu Wang,et al.  Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  G. Martin,et al.  Hematologic Complications , 2014, Non-Pulmonary Complications of Critical Care.

[10]  S. Bari,et al.  Low-dose insulin-like growth factor binding proteins 1 and 2 and angiopoietin-like protein 3 coordinately stimulate ex vivo expansion of human umbilical cord blood hematopoietic stem cells as assayed in NOD/SCID gamma null mice , 2014, Stem Cell Research & Therapy.

[11]  Betül Çelebi,et al.  Insulin-like growth factor binding protein-2 and neurotrophin 3 synergize together to promote the expansion of hematopoietic cells ex vivo. , 2012, Cytokine.

[12]  K. Park,et al.  Endothelial Progenitor Cell Cotransplantation Enhances Islet Engraftment by Rapid Revascularization , 2012, Diabetes.

[13]  D. Lyden,et al.  Megakaryocytes, malignancy and bone marrow vascular niches , 2012, Journal of thrombosis and haemostasis : JTH.

[14]  Xiao-hui Zhang,et al.  Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  Reinier Bron,et al.  Insulin‐like growth factor binding protein‐1 activates integrin‐mediated intracellular signaling and migration in oligodendrocytes , 2010, Journal of neurochemistry.

[16]  C. Wallington-Beddoe,et al.  Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  Yu-Hong Chen,et al.  Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  S. Rafii,et al.  Platelets, petechiae, and preservation of the vascular wall. , 2008, The New England journal of medicine.

[19]  D. Hanauer,et al.  CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantation. , 2007, Blood.

[20]  K. Bradstock,et al.  Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation , 2007, Bone Marrow Transplantation.

[21]  R. Yamazaki,et al.  Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover , 2006, Bone Marrow Transplantation.

[22]  S. Mohan,et al.  The multi-functional role of insulin-like growth factor binding proteins in bone , 2005, Pediatric Nephrology.

[23]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[24]  L. Rybicki,et al.  Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant , 2004, Bone Marrow Transplantation.

[25]  S. Rafii,et al.  Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis , 2004, Nature Medicine.

[26]  Lanping Xu,et al.  [Detection of cytomegalovirus infection by polymerase chain reaction in hematopoietic stem cell transplantation recipients]. , 2003, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[27]  P. Lala,et al.  Insulin-Like Growth Factor-Binding Protein 1 Stimulates Human Trophoblast Migration by Signaling through α5β1 Integrin via Mitogen-Activated Protein Kinase Pathway1 , 2001 .

[28]  K. Sullivan,et al.  Secondary failure of platelet recovery after hematopoietic stem cell transplantation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[29]  M. Beksac,et al.  CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation , 2001, Journal of clinical apheresis.

[30]  P. Lala,et al.  Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein Kinase pathway. , 2001, The Journal of clinical endocrinology and metabolism.

[31]  N. Rosenthal,et al.  Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation , 1998, Bone Marrow Transplantation.

[32]  S. Rafii,et al.  Transendothelial Migration of Megakaryocytes in Response to Stromal Cell-derived Factor 1 (SDF-1) Enhances Platelet Formation , 1998, The Journal of experimental medicine.

[33]  Zhong-ying Liu,et al.  The α-Chemokine Receptor CXCR4 Is Expressed on the Megakaryocytic Lineage From Progenitor to Platelets and Modulates Migration and Adhesion , 1998 .

[34]  J. Vose,et al.  A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. , 1998, Blood.

[35]  S. Frøland,et al.  Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection , 1998 .

[36]  S. Frøland,et al.  Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  J. Groopman,et al.  The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. , 1998, Blood.

[38]  S. Mohan,et al.  Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. , 1997, Endocrine reviews.

[39]  S. Rafii,et al.  Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. , 1995, Blood.

[40]  I. Lauder,et al.  Thrombocytopenia following autologous bone marrow transplantation: evidence for autoimmune aetiology and B cell clonal involvement. , 1995, Bone marrow transplantation.

[41]  J. Armitage.  Bone marrow transplantation. , 1994, The New England journal of medicine.

[42]  K. Pendry,et al.  Factors influencing haematological recovery in 53 patients with acute myeloid leukaemia in first remission after autologous bone marrow transplantation , 1993, British journal of haematology.

[43]  M. Caligiuri,et al.  Immune‐Mediated Cytopenia following Bone Marrow Transplantation Case Reports and Review of the Literature , 1992, Medicine.

[44]  H. Nieuwenhuis,et al.  Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation , 1991 .

[45]  C. Anasetti,et al.  Graft-v-host disease is associated with autoimmune-like thrombocytopenia. , 1989, Blood.

[46]  J. Lipton,et al.  Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. , 1985, Blood.

[47]  M. Tavassoli,et al.  Hemopoietic stromal microenvironment , 1983, American journal of hematology.